Skip to main content
Clinical Trials/IRCT20210308050628N1
IRCT20210308050628N1
Completed
Phase 3

The Assessment of Efficacy for Neoadjuvant Chemotherapy with Modified FOLFOX6 compared to Chemoradiation for the Management of Locally Advanced Rectal Cancer: A Promising Therapeutic Approach

Hamedan University of Medical Sciences0 sites300 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
ocally advanced Rectal cancers.
Sponsor
Hamedan University of Medical Sciences
Enrollment
300
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • age between 18\-75
  • Rectal cancer(Adenocarcinoma) confirmed by pathology
  • locally advanced tumors
  • No distant metastasis
  • Proper Performance status(PS: 0\-1\)
  • proper blood condition
  • proper renal function
  • proper liver function

Exclusion Criteria

  • Recurrent rectal cancer
  • previous pelvic radiotherapy
  • history of other malignancy

Outcomes

Primary Outcomes

Not specified

Similar Trials